Hexabromocyclododecane (HBCD) is an additive flame retardant used primarily in polystyrene foams. HBCD is a persistent contaminant that has been detected in abiotic and biotic matrices, including wild avian species. The toxicological implications of exposure are not well characterized. We recently identified molecular end points responsive to HBCD exposure in chicken embryonic hepatocytes (CEHs) including genes involved in xenobiotic metabolism, thyroid hormone transport, and lipid metabolism. In the current study, a technical mixture of HBCD (HBCD-TM), comprising 12% a-, 11% b-, and 77% g-stereoisomers, was injected into the air cell of chicken eggs prior to incubation. Embryonic viability to pipping, isomer-specific HBCD accumulation, and hepatic mRNA expression of the genes identified in the in vitro study were determined. Concentrations of 100 and 10,000 ng/g decreased pipping success while 50, 300, and 1000 ng/g had no effect. In contrast to HBCD-TM, the isomeric composition in liver tissue was significantly different for a-(31%) and g-HBCD (61%) demonstrating that isomer-specific processes were occurring in the egg and/or developing embryo. Exposure to 1000 ng/g HBCD-TM significantly upregulated cytochrome P450 (CYP) 2H1, CYP3A37, uridine 5#-diphospho-glucuronosyltransferase, and deiodinase 2, while liver fatty acid-binding protein and insulin-growth factor 1 expression were significantly decreased at 100 and 10,000 ng/g, respectively. The alterations in hepatic mRNA levels were in concordance with those observed in CEH highlighting the utility of both approaches for identifying molecular mechanisms of action. Research on the effects of HBCD in wild avian species is warranted.
Hexabromocyclododecane (HBCD) is a brominated flame retardant (BFR) that is incorporated into a wide range of consumer products to hinder or delay flammability. A main application is the incorporation in polystyrene foam boards used for thermal insulation. Other applications include the addition of HBCD to the back coating of textiles in upholstered furniture and to high-impact polystyrene materials in electronic equipment (BSEF, 2009) . HBCD ranks among the largest mass-produced BFRs worldwide, with a global demand of 17,000 metric tons/year (Hale et al., 2006) . Four technical mixtures of HBCD (HBCD-TMs) are available for commercial use and comprise approximately 10% a-, 9% b-, and 81% c-HBCD structural isomers (Tomy et al., 2004; . Since HBCD is an additive flame retardant, it has the potential to leach out of commercial products. Accordingly, the use and/or disposal of such products lead to HBCD accumulation and persistence in the environment.
The potential for HBCD to accumulate in organisms and biomagnify within a food web was initially observed in fish and lower aquatic organisms (Tomy et al., 2004; Veith et al., 1979) , until evidence of its bioaccumulation emerged in top marine predators. Law et al. (2003) detected a sharp increase in HBCD concentrations in harbor porpoises from 2001 onward. This coincided with an increased use of HBCD as a substitute for polybrominated diphenyl ethers. Herring gull (Larus argentatus) eggs from the Great Lakes of North America contained 2.1-20 ng/g wet weight (ww) HBCD (Gauthier et al., 2007) while common tern eggs (Sterna hirundo) from the North Sea had concentrations ranging from 330 to 7100 ng/g lipid weight (lw) (Morris et al., 2004) . Birds dependent upon a terrestrial food web also had detectable levels of HBCD; peregrine falcon (Falco peregrinus) eggs contained 220-520 ng/g lw (Lindberg et al., 2004) . Fernie and Letcher (personal communication) recently reported 0.03 ng/g ww HBCD in plasma of peregrine falcons from heavily populated areas of southern Ontario and western Quebec.
Isomer-specific processes have been shown to result in preferential accumulation of the a-isomer in biotic samples relative to commercial HBCD mixtures that consist mostly of the c-isomer (Covaci et al., 2006; Gauthier et al., 2007; Tomy et al., 2008; Zegers et al., 2005) . Zegers et al. (2005) demonstrated that b-and c-HBCD were significantly metabolized in an in vitro assay while the a-isomer was not. The authors suggested that isomer-specific cytochrome P450 (CYP)-mediated biotransformation was the most likely explanation for exclusive accumulation of a-HBCD in biota occupying high trophic positions.
Given the persistence and accumulation of HBCD in the environment, it is important to elucidate potential mechanisms of molecular and toxic action in order to assess the risk of exposure. There are several pathways that may be affected by HBCD exposure and few studies have assessed potential effects in avian species. In mammals, activation of the pregnane xenobiotic receptor (PXR) and constitutive androstane receptor (CAR) by HBCD was demonstrated in vitro and in vivo via the induction of the phase I metabolizing enzymes, CYP3A1 and CYP2B1 (Germer et al., 2006) . The avian orthologs, CYP3A37 and CYP2H1, were also induced following exposure to HBCD in chicken embryonic hepatocyte (CEH) cultures (Crump et al., 2008 ). An analysis of hepatic gene expression profiles in HBCD-exposed rats identified alterations of genes associated with phase I and II pathways, lipid metabolism, and cholesterol biosynthesis (Canton et al., 2008) . The phase II enzyme, uridine 5#-diphospho-glucuronosyltransferase (UGT) 1A9, increased in CEH treated with HBCD while liver fatty acid-binding protein (L-FABP) decreased (Crump et al., 2008) . Alteration of thyroid hormone (TH) homeostasis was reported in rodents as HBCD decreased circulating T 4 concentrations and increased thyroid-stimulating hormone levels (Chengelis, 2001; van der Ven et al., 2006) . Enhancement of T 3 -mediated effects were demonstrated ex vivo in an amphibian tail tip regression assay (Schriks et al., 2006) , and Hamers et al. (2006) further supported the agonistic activity of HBCD-TM, a, b, and c on T 3 -mediated growth of the rat pituitary tumor GH3 cell line. Finally, Fernie et al. (2009) reported a negative correlation between eggshell thickness and total a-HBCD.
Here, an egg injection study was conducted to determine the effects of HBCD-TM on embryotoxicity, isomer-specific accumulation in liver and cerebral cortex, and hepatic gene expression in the domestic chicken (Gallus gallus domesticus). Injection of HBCD-TM was performed prior to embryogenesis in order to expose embryos during all critical stages of development. Total HBCD concentrations and the proportion of structural isomers in liver and cerebral cortex were determined. Real-time reverse transcription (RT)-PCR was used to assess the effects of HBCD-TM on expression of hepatic genes related to the chicken xenobiotic-sensing orphan nuclear receptor (CXR), the TH pathway, lipid regulation, and growth. We predicted that pipping success of chicken embryos would be high given mammalian data which show that the LD50 was > 6400 mg/kg bw (mice) and > 10,000 mg/kg bw (rats) (reviewed in Darnerud, 2003) . We also tested the hypothesis that genes demonstrating a transcriptional response to HBCD in a chicken hepatocyte in vitro screening assay (Crump et al., 2008) would be altered in hepatic tissue of chicken embryos exposed to HBCD-TM via egg injection. The goal was to determine the predictive capacity of the screening assay in the context of the whole animal.
MATERIALS AND METHODS

Chemicals.
For egg injection studies, HBCD-TM was purchased from Wellington Laboratories (Guelph, ON). For isomer-specific HBCD determinations, mixed standard solutions of a-, b-, and c-1,2,5,6,9,10-HBCD and their 13 C 12 -labeled analogues (Ma-HBCD, Mb-HBCD, and Mc-HBCD) were purchased from Wellington Laboratories.
HBCD-TM was initially dissolved in acetone to increase its solubility in organic safflower oil (Loblaws, Inc., Canada). Acetone was subsequently evaporated under nitrogen gas to yield a safflower oil/HBCD-TM solution. Nominal concentrations of 0.25, 0.5, 1.5, 5, and 50 mg/ml were prepared, and the actual concentrations of the injection solutions were determined by liquid chromatography-electrospray ionization (À)-tandem quadrupole mass spectrometry (LC-ESI(À)-MS-MS) as described below and are listed in Table 1 .
Egg injection and tissue collection. Three separate egg injection experiments were performed and required a total of 218 unincubated White Leghorn chicken (G. gallus domesticus) eggs obtained from the Canadian Food Inspection Agency (Ottawa, ON, Canada). All procedures involving the handling of animals were conducted according to protocols approved by the Animal Care Committee at the National Wildlife Research Centre. In the first experiment, we assessed pipping success, tissue-specific concentrations of HBCD isomers, and hepatic mRNA expression in the following groups: uninjected control (n ¼ 15), safflower oil vehicle (n ¼ 15), 100 ng HBCD-TM/g egg (n ¼ 15), 1000 ng HBCD-TM/g egg (n ¼ 15), and 10,000 ng HBCD-TM/g egg (n ¼ 20). The second and third experiments were conducted to determine pipping success in the following groups: uninjected control (n ¼ 19), vehicle (n ¼ 19 and n ¼ 20), 50 ng HBCD-TM/g egg (n ¼ 20), 100 ng HBCD-TM/g egg (n ¼ 20 and n ¼ 20), 300 ng HBCD-TM/g egg (n ¼ 19), and 1000 ng HBCD-TM/g egg (n ¼ 20).
Eggs were weighed, candled, and the location of the air cell was marked in pencil. Two small holes, approximately 1.5 mm in diameter and 1 cm apart, were drilled into the center of the air cell using a Dremel drilling tool (Dremel MultiPro, model 395) for all eggs except those assigned to the uninjected control group. A sterile 10-ll pipette tip was placed in one of the holes to pierce the membrane and relieve air pressure during injection. A predetermined volume of safflower oil or HBCD-TM working solution, based on the weight of each individual egg (i.e.,~0.2 ll/g egg), was injected into the other hole using a Biohit electronic pipette to attain the desired exposure concentrations described above. After injection, the holes were sealed with a 1.5-cm 2 section of AirPore Tape (Qiagen, Mississauga, ON). The eggs were left at room temperature for 1 h with the air cell pointed upward and then placed horizontally into an incubator (Petersime, Model XI) at 37.5°C and 58% humidity. During incubation, the eggs were candled weekly and cardiac/embryonic vibrations were detected with a Buddy Digital Egg Monitor (Avitronics, England). Infertile or dead eggs were removed and embryos that did not make a pipping star by day 22 were considered unable to hatch. Pipping success was determined by dividing the number of embryos that pipped by day 22 by the number of total fertile eggs per treatment group.
Embryos that pipped successfully were euthanized by decapitation, and portions of the liver were removed, flash-frozen in liquid nitrogen, and stored at À80°C until subsequent RNA extraction. The remaining liver from five individuals per treatment group were randomly sampled for HBCD analysis by LC-ESI(À)-MS-MS. Cerebral cortex samples from the same five individuals per treatment group were collected for chemical residue analysis; RNA was not extracted from these samples. Finally, blood (live embryos) or a portion of tissue (dead embryos) was collected for genetic sex determination.
Determination of HBCD isomers by LC-ESI(À)-MS-MS.
Tissue and injection stock solution samples were weighed, transferred to a glass mortar, and ground with~5 g of diatomaceous earth; 10 ng of each internal standard (Ma-, Mb-, Mc-HBCD) were spiked into the sample prior to extraction using accelerated solvent extraction (ASE200; Dionex Company, Sunnyvale, CA) with dichloromethane/hexane (50/50, vol/vol). The operation parameters were three cycles of: heat for 5 min, static for 5 min, flush 100%, and purge for 30 s
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(pressure, 1500 psi; temperature, 100°C). The extract was concentrated and cleaned up by sulfuric acid silica (50%) (Janak et al., 2005) . The eluant, containing target compounds, was collected, concentrated, and solvent exchanged to methanol for LC-ESI(À)-MS-MS analysis.
The analysis was performed using a Waters 2695 liquid chromatograph equipped with an ACE 3 C 18 analytical column (2.1 3 50 mm, 3 lm particle size; Advanced Chromatography Technologies, Aberdeen, UK). The temperature of the LC column was kept at 40°C. The mobile phase consisted of water, acetonitrile, and methanol, and the LC flow rate was 0.25 ml/min. The following gradient was employed: water/acetonitrile/methanol (40/40/20) linear gradient changed to acetonitrile/methanol (60/40) after 3 min and held for 8 min, followed by a return to the initial gradient conditions for 30 s and equilibrated for 9.5 min. A 10-ll aliquot of the sample was injected into the LC system.
The mass spectrometer was a Waters QuattroUltima triple-quadrupole mass spectrometer (Waters, Milford, MA) with an ESI source in the negative mode. Nitrogen was used as a nebulizing and dissolvent gas, and argon was used as the collision gas. Multiple reaction monitoring mode was used and the monitored transitions were 640.5 > 81 and 652.5 > 81 for analytes (a-, b-and c-HBCD) and internal standards (Ma-, Mb-, and Mc-HBCD), respectively. The data analysis was performed using QuanLynx software, Version 4.0. Quantification was performed using an internal standard method with a fivepoint calibration curve spanning the range of anticipated analyte concentrations in the samples.
The method detection limit (MDL) value was measured by performing replicate analyses (n ¼ 8) of chicken egg samples, which were spiked with analytes. The MDL was calculated as three times the SD of the measured concentration of target compounds. The MDLs for a-, b-, and c-HBCD were 0.2, 0.2, and 0.32 ng/g ww, respectively. The recovery efficiencies of the Ma-, Mb-, and Mc-HBCD internal standards ranged from 70 to 100%. As the internal standard method of quantification was used, isomer-specific HBCD concentrations in the samples and spiking solutions were inherently recovery corrected.
Genetic sex determination by PCR. Genomic DNA was extracted from 10 to 25 ll of whole blood or a small (~5 mg) piece of tissue by suspending it in 100 ll 5% Chelex solution (Sigma-Aldrich, St Louis). Chelex is a chelating resin that binds bivalent metal ions to inhibit the breakdown of DNA during heating (Ellegren, 1992) . The samples were vortexed thoroughly and incubated at 95°C for 5 min. Sex was determined by PCR using the 2550F/2718R primer set as previously described (Fridolfson and Ellegren, 1999) .
Real-time RT-PCR. RNA was extracted from 20 to 50 mg of liver (n ¼ 5-10/treatment group) using Trizol reagent according to the manufacturer's instructions (Invitrogen, Burlington, ON) and subsequently treated with DNase using DNA-free kits (Ambion, Austin, TX). The concentration and purity of extracted RNA was determined by measuring the A 260 /A 280 ratio on a UV/Vis SpectraMax 190 plate reader (Molecular Devices Corp., Sunnyvale, CA). A standard concentration of 50 ng/ll RNA was reverse transcribed to cDNA using SuperScript II and random hexamer primers as described by the manufacturer (Invitrogen). To assess the presence of contaminating genomic DNA, reactions containing template RNA without reverse transcriptase were prepared in parallel (no-RT control). A 1:40 dilution of cDNA was prepared with diethylpyrocarbonate-treated water and stored at À80°C.
Primer pairs and Taqman fluorogenic probes were previously designed for the following transcripts: b-actin, CYP2H1, CYP3A37, UGT1A9, and L-FABP (Crump et al., 2008) . For this study, primers and probes were also designed for deiodinase 2 (DI2) (forward 5#-GTGTTGCAGCACCTGGTAGC-3, 900nM; reverse 5#-TGTTTCTCGGCTATT TAAGCACTG-3#, 300nM; probe 5#-CAGACCTCCCGCTCCCGTGTCAGT-3#, 200nM) and insulin-like growth factor-1 (IGF-1) (forward 5#-TGCTCCAATAAAGCCACCTAAATC-3#, 900nM; reverse 5#-TTCTGTTTCCTGTGTTCCCTCTAC-3#, 900nM; probe 5#-ACGCTCTGTACGTGCTCAGCGCCA-3#, 200nM). All assays were run using the Stratagene Mx3000P or Mx3005P (Stratagene, La Jolla, CA) and Brilliant QPCR Core Reagent kits (Stratagene). Each 25 ll reaction contained primers and probes, 13 Core PCR buffer, 5mM MgCl 2 , 0.8mM dNTPs, 1.25 U SureStart Taq polymerase, 8% glycerol, 75nM ROX reference dye, and 5 ll diluted cDNA. The thermocycle program included an enzyme activation step at 95°C (10 min) and 40 cycles of 95°C (30 s) and 60°C (1 min). All gene targets were run with the normalizer gene, b-actin. The mRNA expression levels of b-actin were invariable across treatment groups, and it was therefore considered an appropriate normalizer.
Reaction efficiencies for all multiplex assays were determined using a standard curve that was generated from a 1:2 dilution series of cDNA. Primer concentrations were optimized to ensure that the reaction efficiencies of all genes were similar to that of b-actin. cDNA from 5 to 10 individual embryos per treatment group were run in duplicate for each assay. No RT and no template controls were included to verify the absence of contamination.
Cycle threshold (Ct) data were normalized to b-actin and the fold change in target gene mRNA abundance in HBCD treatment groups compared to the vehicle control was calculated using the 2 ÀDCt equation (Schmittgen and Livak, 2008) . Statistically significant differences in mRNA expression were identified by performing a one-way ANOVA to 2 ÀDCt -transformed data followed by a Bonferroni's t-test for multiple comparisons versus the vehicle control 
RESULTS
Effects of HBCD-TM on Pipping Success
In the first egg injection study, pipping success was 35% in embryos exposed to the highest dose group of 10,000 ng/g and 64% in the 100 ng/g treatment group (Table 1) . Based on the reduced pipping success in one of the low treatment groups (100 ng/g), two additional studies were conducted and results from all three studies combined demonstrated that pipping success was significantly decreased to 71% at 100 ng/g compared to the vehicle control (n ¼ 3 independent studies; Table 1 ). The uninjected control, vehicle control, 50 ng/g, 300 ng/g, and 1000 ng/g had no effect on pipping success indicating an atypical dose-response (Table 1) . Pipping success was independent of embryo sex (data not shown).
Isomer-Specific HBCD Concentrations and Patterns
The P -HBCD concentrations of the HBCD-TM working solutions were 0.22, 0.43, and 4.98 mg/ml. These were very close to the target nominal concentrations of 0.25, 0.5, and 5 mg/ml (Table 1 ). There was a significant linear correlation between treatment group and actual P -HBCD concentration in liver (r 2 ¼ 0.72; p < 0.0001). Concentrations increased in a dose-dependent manner to a maximum of 1170 ng/g ww in the 10,000 ng/g group (Table 1) . Concentrations in cerebral cortex also increased in a dose-dependent manner to a maximum of 102 ng/g ww in the 10,000 ng/g group (Table 1) . These concentrations are approximately 10 and 100 times lower than the nominal injected concentration for liver and cerebral cortex, respectively. The linear relationship observed for tissue concentration was not apparent for pipping success.
The isomer-specific content of the stock HBCD-TM solution was characterized and comprised 12.5, 11.1, and 76.4% a-, b-, and c-isomers, respectively (Table 2) . A significantly different isomeric ratio was detected in liver tissue compared to the safflower oil stock solution in which a-HBCD increased to 31.2% and c-HBCD decreased to 60.4%. No significant changes were observed for b-HBCD in liver tissue or a-, b-, and c-HBCD in cerebral cortex (Table 2) .
Hepatic mRNA Expression
Hepatic mRNA expression of two phase I metabolizing enzymes, CYP2H1 and CYP3A37, was induced in chicken embryos exposed to HBCD-TM. CYP2H1 was significantly induced by fourfold at 1000 ng/g while CYP3A37 increased by 15-and 10-fold at 1000 and 10,000 ng/g, respectively (Figs. 1A and 1B) . We observed a fivefold induction in hepatic mRNA expression of the phase II metabolizing enzyme, UGT1A9, in chicken embryos exposed to 1000 ng/g HBCD-TM (Fig. 1C) . DI2 mRNA expression was upregulated sevenfold in the 1000-ng/g HBCD-TM group and L-FABP was downregulated at 100 ng/g (Figs. 1D and 1E) . Finally, IGF-1 mRNA was significantly downregulated (ca. fivefold) in liver tissue of chicken embryos exposed to 10,000 ng/g HBCD-TM in ovo (Fig. 1F) .
DISCUSSION
To our knowledge, this is the first egg injection study to determine the effects of HBCD-TM exposure on embryotoxicity, isomer-specific accumulation, and hepatic mRNA expression in an avian species. Such an assessment is important given the persistence and accumulation of HBCD in tissues, blood, and eggs of free-living avian species worldwide. Injected concentrations similar to those detected in avian species (i.e., 100 ng/g) impacted pipping success of the domestic chicken. Additionally, genes associated with xenobiotic metabolism, TH homeostasis, lipid regulation, and growth were transcriptionally active in hepatic tissue from embryos exposed to HBCD in ovo.
There are no published reports to date describing potential toxic effects of HBCD in avian species. Survival to pipping was significantly decreased in three independent experiments to an average of 70.9% in the 100 ng/g group compared to the vehicle control. Exposure to 10,000 ng/g HBCD-TM also decreased pipping success (to 35%) while 50, 300, and 1000 ng/g had no effect. This atypical relationship was dissimilar from the significant linear relationship observed between treatment concentration and liver HBCD concentration (discussed in more detail below). Embryonic death was observed in embryos > embryonic stage 27, with the majority of mortality occurring between stages 35 and 41 (Hamilton and Hamburger, 1951) . Therefore, the toxic effects of HBCD occurred after initial embryogenesis which has been identified as a particularly sensitive developmental stage in egg injection studies with other chemicals (DeWitt et al. 2005; Heinz et al., 2006) . In zebrafish, the survival rate of embryos, exposed to concentrations of HBCD greater than those measured in surface 
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waters (0.05-1 mg/l), was significantly decreased by as much as 66.7% (Deng et al., 2009) . HBCD toxicity has also been investigated in rodents; however, different administration methods were employed. Following a single po administration, no increase in death rate was observed in mice or rats and the LD 50 was determined to be > 6400 mg/kg bw (mice) and > 10,000 mg/kg bw (rats) (reviewed in Darnerud, 2003) . A No Observable Adverse Effect Level (NOAEL) of 1000 mg/kg bw/ day was calculated for both 28-and 90-day repeated dose oral toxicity studies with rats (Chengelis, 1996 (Chengelis, , 2001 ). Thus, in rodents, acute toxicity of HBCD appears to be very low. However, in fish and birds, embryonic development appears to be a sensitive stage for HBCD to exert toxic effects. Follow-up work is warranted with other avian and fish species to determine the mechanisms of toxic action and to further explore the nature of the atypical dose-response observed in avian embryos.
It was imperative to determine the concentration of the HBCD-TM stock solutions to ensure there were no errors in preparation that could explain why the 100 and 10,000 ng/g groups had a significant effect on viability while the 1000 ng/g group did not. The stock concentrations were 0.43 and 4.98 mg/ml for the 100 and 1000 ng/g groups, respectively, indicating that the nominal treatment groups were correct. Determination of isomer-specific HBCDs in liver tissue provided further evidence that the treatment groups were accurate as there was a significant linear correlation between these two variables. The average concentrations were 29 and 114 ng/g, in the 100 and 1000 ng/g groups, respectively. These concentrations are approximately 10 times lower than the concentration administered at the beginning of incubation. HBCD levels were also measured in cerebral cortex and the concentrations were approximately 10 times lower than those
FIG. 1. The relative mRNA expression of CYP2H1 (A), CYP3A37 (B), UGT1A9 (C), DI2 (D), L-FABP (E)
, and IGF-I (F) in hepatic tissue of chicken embryos sampled at pipping following exposure to the vehicle control and 100, 1000, and 10,000 ng/g HBCD-TM (administered via egg injection). mRNA abundance was determined by real-time RT-PCR and fold changes were calculated based on the safflower oil vehicle control using 2 ÀDCt -transformed data. Error bars represent the SEM and a one-way ANOVA was used to determine significant differences (n ¼ 5-10; *p < 0.05, **p < 0.01).
496 CRUMP ET AL. in liver from the same treatment group. Brain tissue of dead and dying glaucous gulls (L. hyperboreus) had a-HBCD concentrations of 30 ng/g (Sagerup et al., 2009) . This is similar to concentrations detected in chicken cerebral cortex of embryos exposed to 1000 ng/g HBCD-TM in ovo. Thus, there is evidence that HBCD can accumulate in neuronal tissue. Future work could continue monitoring HBCD in brain tissue of wild avian species and focus on the effects of HBCD on the central nervous system as there are studies which indicate it may be a target. HBCD induced cell death in rat cerebellar granule cells at low micromolar concentrations (Reistad et al., 2006) and dopamine-dependent behavior and brainstem auditory evoked potentials were altered in a one-generation reproduction study with rats .
The isomeric content of the stock HBCD-TM solution used in this study comprised 12.5, 11.1, and 76.4% a-, b-, and c-HBCD isomers, respectively. This is typical of technical mixtures; however, it is not reflective of isomer profiles detected in wildlife, particularly birds, in the environment . In liver tissue of pipping chicken embryos, exposed to HBCD-TM via injection prior to incubation, we detected a significantly different isomeric composition compared to the safflower oil stock solution. a-HBCD increased to 31.2% and c-HBCD decreased to 60.4% while b-HBCD exhibited no significant change. This indicated that isomer-specific processes were occurring in the egg and/or developing embryo (e.g., biotransformation in the liver) after 19-20 days of exposure in ovo. a-HBCD also increased in cerebral cortex but the change was not significant. It was accompanied by a nonsignificant decrease in cerebral cortex c-HBCD. The isomeric shift in chicken embryos mirrors that which is observed in high trophic-level biota, although not to the same extent. Exclusive a-HBCD accumulation was observed in harbor porpoises and common dolphin (Morris et al., 2004; Zegers et al., 2005) , and Tomy et al. (2008) reported a predominance (~80-90%) of a-HBCD in upper trophic-level organisms including beluga, narwhal, arctic cod, and redfish. Herring gull eggs from the Great Lakes contained between 2 and 20 ng/g ww total HBCD, the majority of which comprised the a-isomer (Gauthier et al., 2007) . In juvenile rainbow trout, the a-isomer was recalcitrant to bioisomerization and was bioformed from both the b-and c-isomers , suggesting that isomer-selective bioisomerization may play a role in isomer distribution of HBCD in biota.
An enhanced metabolic capability of upper trophic level biota to biotransform b-and c-HBCD has also been proposed to explain the predominance of a-HBCD. Adult female C57BL/6 mice, gavaged with 14 Ca-or c-HBCD, showed selective tissue accumulation of a-relative to c-HBCD due to a faster rate of metabolism of the latter isomer (Szabo, Diliberto, Huwe, and Birnbaum, unpublished data) . In vitro assays with rat and harbor seal liver microsomes demonstrated that b-and c-HBCD were significantly metabolized by the cytochrome P450 system while a-HBCD was not; only monohydroxy metabolites derived from b-and c-HBCD were detected (Zegers et al., 2005) . Metabolites were not measured in the present study but could be in future studies to determine if the shift observed in isomeric ratio in chicken liver was due to different rates of CYP-mediated biotransformation. Although CYPs are present in many organs, the liver is the major site of activity. This might help explain the significant shift in isomeric composition in chicken embryonic liver tissue versus the nonsignificant shift in cerebral cortex where CYP expression would be predicted to be lower.
One of the main objectives of this study was to determine if gene transcripts that were identified as HBCD responsive in an earlier in vitro study (Crump et al., 2008) were transcriptionally active in hepatic tissue from embryos exposed to HBCD in ovo. The mRNA expression levels of two CXR-regulated phase I metabolizing genes, CYP2H1 and CYP3A37, were induced to a maximum of 4-and 15-fold, respectively, at 1000 ng/g HBCD-TM followed by a slight decrease at 10,000 ng/g. These results not only identify potential molecular mechanisms of HBCD action but also provide a possible explanation for the shift in isomeric content observed in liver tissue (i.e., CYPmediated biotransformation). An induction of CYP2H1 and CYP3A37 mRNA was also observed in CEH exposed to HBCD-TM, where CYP3A37 was induced to a greater extent (Crump et al., 2008) , corroborating the effects observed in ovo (Table 3) . This is consistent with mammalian data which showed a greater induction of CYP3A compared to CYP2B (orthologs of the avian CYP3A37 and CYP2H1) following HBCD-TM exposure (Germer et al., 2006) . CYP3A mRNA and enzyme activity were both induced in primary rat hepatocyte cultures by HBCD-TM (Fery et al., 2009) providing further evidence that CYP3A induction is among the most sensitive end points of HBCD exposure. In fact, the 15-fold induction of CYP3A37 by 1000 ng/g HBCD-TM in this study was the greatest among the six genes tested. Canton et al. (2008) also found that CYP3A3 was the most responsive gene in rats exposed to HBCD. 
Note. ND, not determined.
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Additionally, certain transcripts (e.g., UGT1A1, CYP3A3, and CYP3A13) were maximally induced at 30 mg/kg/day followed by a slight decrease at 100 mg/kg/day, a finding similar to that for the CYPs, UGT1A9, and DI2 in this study. Thus, phase I metabolizing enzymes, associated with PXR/CAR (mammals) and CXR (birds) activation, are responsive to HBCD exposure. Fery et al. (2009) suggested that the consequences of PXR activation were not limited to alterations in drug-metabolizing enzymes but could also include changes in endogenous metabolism of hormones and lipids. This has led to the suggestion that persistent PXR agonists could be considered ''endocrine disruptors'' (Mikamo et al., 2003) . The phase II enzyme, UGT1A9, was induced in chicken hepatic tissue following exposure to 1000 ng/g HBCD-TM which was in concordance with results obtained in the in vitro CEH culture study (Crump et al., 2008;  Table 3 ). The expression of the mammalian ortholog, UGT1A1, is regulated by PXR/CAR in mammals and is the major T 4 -conjugating UGT that renders T 4 excretable by the kidneys (Germer et al., 2006; Mackenzie et al., 2003) . UGTs in combination with the biliary conjugate export pump, Mrp2, can lead to massive depletions in blood T 4 levels (Wong et al., 2005) . T 4 levels were significantly reduced in HBCD-exposed rats (Chengelis, 2001; van der Ven et al., 2006) and accompanied by a dose-dependent increase in T 4 -UGT activity (van der Ven et al., 2006). Canton et al. (2008) reported an induction of UGT1A1 mRNA in rat hepatic tissue following HBCD exposure. Another proposed mechanism behind reduced plasma T 4 concentrations is the enhanced conversion of T 4 to T 3 through hepatic monodeiodinase enzymes. DI2 is involved in outer ring 5#-deiodination of T 4 , and an upregulation, as observed in this study (ca. sevenfold), could enhance the conversion and deplete circulating levels. Circulating T 4 and T 3 levels were not determined in the present study but should be measured in future studies to establish a more concrete link between gene expression end points and circulating hormone levels.
Gene expression analysis in PXR-null mice revealed a role for PXR in regulating the transcription of genes associated with lipid uptake, transport, biosynthesis, oxidation, and storage (Dai et al., 2008) . Roth et al. (2008) also identified a role for PXR in lipid homeostasis. In chicken embryos exposed via injection to HBCD-TM, L-FABP mRNA was downregulated in the 100 ng/g dose group. This expression pattern follows the atypical viability response to a certain extent. However, at the dose that elicited the greatest impact on pipping success (10,000 ng/g), L-FABP levels were similar to those observed in the vehicle control. A downregulation of L-FABP was also observed in CEH treated with HBCD (Crump et al., 2008) ; however, the response was concentration dependent in contrast to the in ovo effect which was only apparent at a single dose. HBCD exposure downregulated several genes associated with lipid metabolism/regulation, including fatty acid-binding protein in rat hepatic tissue (Canton et al., 2008) . L-FABP is a member of a superfamily of lipid-binding proteins and plays a role in the metabolism and intracellular transportation of lipids (Wang et al., 2006) . There is some evidence to suggest that L-FABP mRNA expression is TH dependent as levels were induced by T 3 in hypothyroid Wistar rats (Iwen et al., 2001) . The link between TH status and TH-dependent genes such as L-FABP should be further explored as both hormone and lipid homeostasis appear to be potential targets of HBCD exposure.
Finally, IGF-1 was also downregulated by in ovo HBCD-TM exposure, albeit only in the highest dose group (10,000 ng/g). IGF-I along with growth hormone (GH) and T 3 are required to support normal growth in birds (Scanes, 2009) . Polychlorinated biphenyls (PCBs) have been shown to reduce growth in several avian species (Hoffman et al., 1986 (Hoffman et al., , 1987 ; however, circulating plasma IGF-I levels were not affected in chickens exposed to PCBs; liver IGF-I mRNA levels were not assessed (Gould et al., 1997) . We did not weigh the chicken embryos at pipping in order to quantify somatic growth or measure circulating plasma IGF-I levels, but this could be done in future studies to help establish a link between molecular and physiological end points. In addition to its role in normal growth, IGF-I is associated with TH status and lipid homeostasis; two end points that appear vulnerable to HBCD exposure in birds. In chicken liver, mRNA expression of IGF-I was significantly repressed by propylthiouracil, but recovery was observed following T 4 replacement (Tsukada et al., 1998) . Further, treatment with IGF-I increased growth rate in an additive manner with T 3 in dwarf chickens lacking the GH receptor (Tixier-Boichard et al., 1992) . The GH-IGF-I axis could be explored in more detail especially in terms of the cross-talk with the TH axis and its responsiveness to HBCD and other environmental contaminants of interest.
In conclusion, pipping success of chicken embryos was significantly reduced by 100 and 10,000 ng/g HBCD-TM, and the isomeric composition was significantly altered in hepatic, but not cortical, tissue. Genes associated with phase I and II metabolism, TH homeostasis, lipid regulation, and the GH-IGF-I axis were altered by HBCD-TM. Several of these cellular responses have been linked, in mammals, to PXR activation highlighting the importance of receptor activation in mediating a response to environmental contaminants. The concordance of transcriptional responses between in vitro (Crump et al., 2008) and in ovo (this study) approaches (Table 3) indicates that these genes are useful molecular markers of HBCD exposure. To further validate the in ovo findings, it will be important to assess the effects on protein expression of the mRNA targets and to conduct studies with wild avian species to determine if these markers are applicable to individuals that are naturally exposed to HBCD and other environmental contaminants.
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